William H Herman Selected Research

Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)

1/2022	National Trends in the Achievement of Recommended Strategies for Stroke Prevention in U.S. Adults With Type 2 Diabetes, 2001-2018.
1/2022	Diabetic Peripheral Neuropathy and Urological Complications in Type 1 Diabetes: Findings From the Epidemiology of Diabetes Interventions and Complications Study.
6/2003	Cost effectiveness of statin therapy for the primary prevention of major coronary events in individuals with type 2 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

William H Herman Research Topics

Disease

62	Type 2 Diabetes Mellitus (MODY) 01/2024 - 10/2002
16	Obesity 01/2023 - 08/2006
15	Glucose Intolerance 02/2024 - 02/2003
14	Prediabetic State (Prediabetes) 09/2023 - 10/2013
13	Insulin Resistance 01/2021 - 10/2002
12	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2024 - 01/2004
10	Stroke (Strokes) 02/2023 - 12/2002
10	Hypertension (High Blood Pressure) 01/2022 - 03/2002
9	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 03/2002
9	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 01/2006
9	Heart Failure 01/2021 - 12/2002
8	Peripheral Nervous System Diseases (PNS Diseases) 02/2024 - 08/2006
8	Myocardial Infarction 01/2021 - 12/2005
7	Chronic Kidney Failure (Chronic Renal Failure) 01/2023 - 03/2003
7	Diabetes Complications 03/2016 - 08/2003
6	Weight Loss (Weight Reduction) 01/2024 - 01/2008
6	Overweight 01/2023 - 11/2007
6	Hyperglycemia 01/2018 - 03/2008
6	Diabetes Mellitus 01/2017 - 05/2003
6	Human Influenza (Influenza) 11/2014 - 07/2004
5	Body Weight (Weight, Body) 01/2023 - 06/2009
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 01/2004
5	Dyslipidemias (Dyslipidemia) 01/2015 - 10/2002
5	Weight Gain 02/2011 - 12/2006
4	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2023 - 12/2005
4	Gestational Diabetes (Gestational Diabetes Mellitus) 10/2022 - 12/2006
4	Albuminuria 11/2018 - 03/2002
4	Proteinuria 09/2009 - 03/2002
3	Morbid Obesity 01/2020 - 01/2015
3	Diabetic Nephropathies (Diabetic Nephropathy) 07/2010 - 08/2003
2	Transient Ischemic Attack 02/2023 - 11/2012
2	Macular Edema 01/2023 - 12/2005
2	Kidney Diseases (Kidney Disease) 01/2023 - 01/2023
2	Metabolic Diseases (Metabolic Disease) 06/2022 - 01/2021
2	Hemoglobinopathies 01/2019 - 07/2008
2	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 12/2016 - 10/2003
2	Ulcer 01/2016 - 06/2013
2	Coronary Disease (Coronary Heart Disease) 05/2013 - 06/2012
2	Hemiplegia (Spastic Hemiplegia) 05/2013 - 11/2012
2	Diabetic Neuropathies (Diabetic Neuropathy) 11/2012 - 08/2010
2	Peripheral Vascular Diseases (Peripheral Vascular Disease) 11/2012 - 08/2003
2	Foot Ulcer 10/2007 - 12/2002
1	Neuralgia (Stump Neuralgia) 02/2024
1	Isolated Systolic Hypertension 11/2022

Drug/Important Bio-Agent (IBA)

42	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 02/2003
31	Insulin (Novolin)FDA Link 11/2022 - 08/2003
24	Metformin (Glucophage)FDA LinkGeneric 01/2024 - 10/2002
18	Hemoglobins (Hemoglobin)IBA 01/2023 - 04/2007
14	Hypoglycemic Agents (Hypoglycemics)IBA 01/2023 - 05/2003
9	Rosiglitazone (Avandia)FDA Link 05/2011 - 10/2002
8	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 07/2004
7	Insulin Glargine (Lantus)FDA Link 01/2024 - 07/2005
7	LipidsIBA 09/2023 - 07/2004
6	CreatinineIBA 01/2023 - 03/2002
6	LDL CholesterolIBA 01/2022 - 06/2003
6	Triglycerides (Triacylglycerol)IBA 01/2022 - 06/2010
6	Glyburide (Glibenclamide)FDA LinkGeneric 05/2011 - 10/2002
5	AlbuminsIBA 01/2023 - 10/2002
5	Antihypertensive Agents (Antihypertensives)IBA 11/2022 - 03/2003
5	HDL CholesterolIBA 01/2022 - 01/2004
5	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021 - 12/2006
5	Blood Glucose (Blood Sugar)IBA 01/2020 - 01/2006
5	Insulin Lispro (Humalog)FDA Link 07/2011 - 07/2005
4	4-nitro-3-dimethylaminopropiophenoneIBA 09/2023 - 01/2021
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022 - 03/2003
4	ThiazolidinedionesIBA 01/2020 - 12/2006
4	Retinaldehyde (Retinal)IBA 09/2009 - 07/2004
3	Biomarkers (Surrogate Marker)IBA 02/2023 - 01/2010
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2005
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 06/2003
3	omega-Chloroacetophenone (Mace)IBA 01/2021 - 01/2020
3	empagliflozinIBA 01/2020 - 07/2018
3	Exenatide (Byetta)FDA Link 12/2011 - 01/2011
3	C-Reactive ProteinIBA 01/2010 - 10/2002
2	NAD (NADH)IBA 02/2024 - 01/2022
2	Liraglutide FDA Link 01/2024 - 01/2020
2	AdipokinesIBA 06/2022 - 01/2021
2	Angiotensin Receptor AntagonistsIBA 01/2022 - 08/2006
2	CanagliflozinIBA 01/2020 - 01/2020
2	1,5-anhydroglucitolIBA 06/2012 - 05/2009
2	SuspensionsIBA 07/2011 - 02/2011
2	Protamines (Protamine Sulfate)FDA Link 07/2011 - 02/2011
2	2,4-thiazolidinedione (thiazolidinedione)IBA 07/2011 - 07/2010
2	CholesterolIBA 01/2010 - 08/2006
2	Fibrinogen (Factor I)FDA Link 08/2006 - 10/2002
2	AntigensIBA 08/2006 - 10/2002
2	Angiotensin IIIBA 01/2006 - 03/2003
2	Losartan (Cozaar)FDA LinkGeneric 01/2006 - 03/2003
1	glimepiride (Amarel)FDA LinkGeneric 01/2024
1	CytokinesIBA 06/2022
1	PhenolsIBA 06/2022
1	ParabensIBA 06/2022

Therapy/Procedure

25	Therapeutics 01/2022 - 03/2003
21	Glycemic Control 01/2022 - 10/2002
7	Bariatric Surgery 01/2017 - 07/2010
6	Surgical Amputation (Amputations) 01/2023 - 12/2002
5	Injections 01/2017 - 07/2005
2	Drug Therapy (Chemotherapy) 01/2022 - 12/2006
2	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2018 - 12/2016
1	Carotid Endarterectomy 02/2023